Lundbeck
HLUN-B.CO
#2695
Rank
C$9.28 B
Marketcap
C$9.36
Share price
0.65%
Change (1 day)
18.15%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): C$0.85

According to Lundbeck's latest financial reports the company's current EPS (TTM) is C$0.87. an increase over its 2024 EPS that were of C$0.63.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
2025C$0.7214.5%
2024C$0.6329.29%
2023C$0.4923.09%
2022C$0.3937.26%
2021C$0.29-84.61%
2020C$1.87-24.61%
2019C$2.48-42.06%
2018C$4.2840.7%
2017C$3.04146.26%
2016C$1.23-120.48%
2015C-$6.033231.32%
2014C-$0.18-115.78%
2013C$1.15-23.36%
2012C$1.50-48.01%
2011C$2.88-9.68%
2010C$3.1913.72%
2009C$2.8024.32%
2008C$2.25-6.05%
2007C$2.4081.77%
2006C$1.32-16.76%
2005C$1.59-17.58%
2004C$1.92